VIVS · Company research
VivoSim Labs, Inc. Common Stock (VIVS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| VivoSim (VIVS) Suffers -2.70% Decline on Heavy Selling 2026-10-14 - Leveraged ETF Flow - www.siam.in | VivoSim (VIVS) Suffers -2.70% Decline on Heavy Selling 2026-10-14 - Leveraged ETF Flow www.siam.in | View source ↗ | www.siam.in | Oct 14, 2026 | neutral | 0 | 0.6 |
| VivoSim Labs (Nasdaq:VIVS) - Stock Analysis - Simply Wall Street | VivoSim Labs (Nasdaq:VIVS) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Oct 11, 2026 | neutral | 0 | 0.6 |
| VivoSim (VIVS) Welcomes FDA's Shift to Non-Animal Testing Methods - GuruFocus | VivoSim (VIVS) Welcomes FDA's Shift to Non-Animal Testing Methods GuruFocus | View source ↗ | GuruFocus | Oct 7, 2026 | neutral | 0 | 0.6 |
| 4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch - www.marketscreener.com | 4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch www.marketscreener.com | View source ↗ | www.marketscreener.com | Oct 7, 2026 | neutral | 0 | 0.6 |
| 4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch - The Killeen Daily Herald | 4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch The Killeen Daily Herald | View source ↗ | The Killeen Daily Herald | Oct 7, 2026 | neutral | 0 | 0.6 |
| Human-cell tests can flag liver risks before clinical trials, VivoSim says. - Stock Titan | Human-cell tests can flag liver risks before clinical trials, VivoSim says. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| VivoSim Labs Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView | VivoSim Labs Disclosed Failure to Satisfy a Continued Listing Rule or Standard TradingView | View source ↗ | TradingView | Aug 21, 2026 | neutral | 0 | 0.6 |
| VIVOSIM LABS Q1 2026 Earnings Preview: Recent $VIVS Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative | VIVOSIM LABS Q1 2026 Earnings Preview: Recent $VIVS Insider Trading, Hedge Fund Activity, and More Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 7, 2026 | neutral | 0 | 0.6 |
| VIVOSIM LABS Q1 2026 Earnings Preview: Recent $VIVS Insider Trading, Hedge Fund Activity, and More - Moomoo | VIVOSIM LABS Q1 2026 Earnings Preview: Recent $VIVS Insider Trading, Hedge Fund Activity, and More Moomoo | View source ↗ | Moomoo | Aug 7, 2026 | neutral | 0 | 0.6 |
| VivoSim reports 13.4M shares outstanding after July warrant exercises - Stock Titan | VivoSim reports 13.4M shares outstanding after July warrant exercises Stock Titan | View source ↗ | Stock Titan | Aug 6, 2026 | neutral | 0 | 0.6 |
| Why Is VivoSim Labs Stock Falling Thursday? - Benzinga | Why Is VivoSim Labs Stock Falling Thursday? Benzinga | View source ↗ | Benzinga | Jul 16, 2026 | neutral | 0 | 0.6 |
| VivoSim Announces Pricing of $4.0 Million Private Placement - GlobeNewswire | VivoSim Announces Pricing of $4.0 Million Private Placement GlobeNewswire | View source ↗ | GlobeNewswire | Jul 16, 2026 | neutral | 0 | 0.6 |
| In today's session, these stocks are experiencing unusual volume. - ChartMill | In today's session, these stocks are experiencing unusual volume. ChartMill | View source ↗ | ChartMill | Jul 16, 2026 | neutral | 0 | 0.6 |
| VIVS Stock Whipsaws As Traders Target Volatile Moves - StocksToTrade | VIVS Stock Whipsaws As Traders Target Volatile Moves StocksToTrade | View source ↗ | StocksToTrade | Jul 15, 2026 | neutral | 0 | 0.6 |
| VivoSim Receives $5 Million Milestone Payment From Eli Lilly and Forecasts 500%+ FY2027 Revenue Growth - Yahoo Finance | VivoSim Receives $5 Million Milestone Payment From Eli Lilly and Forecasts 500%+ FY2027 Revenue Growth Yahoo Finance | View source ↗ | Yahoo Finance | Jul 15, 2026 | neutral | 0 | 0.6 |
| VIVS Predicts Over 500% Revenue Growth by Fiscal Year 2027 - GuruFocus | VIVS Predicts Over 500% Revenue Growth by Fiscal Year 2027 GuruFocus | View source ↗ | GuruFocus | Jul 15, 2026 | neutral | 0 | 0.6 |
| Why Is VIVS Stock Up 79% Today? - Stocktwits | Why Is VIVS Stock Up 79% Today? Stocktwits | View source ↗ | Stocktwits | Jan 30, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.